Active	Status	Sponsor type	Region	Phase	Filter
7 Active 2 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LAMBERT, Juliette
ALFA2101, NCT05260528: CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics	Recruiting	2	210	Europe	Cytarabine and Idarubicin, CPX-315	Centre Hospitalier Universitaire de Nice, Jazz Pharmaceuticals, Acute Leukemia French Association	Acute Myeloid Leukemia	10/27	10/27